| Financial Year |
March 31 2023 |
| Monetary Funds |
397,165,839.33 |
| Held-for-trading Financial Assets |
154,282,561.22 |
| Notes Receivable |
4,389,356.30 |
| Accounts Receivable |
94,667,159.38 |
| Advances to Suppliers |
3,148,488.41 |
| Other Receivables |
16,720,405.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
361,057,482.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
465,221,000.00 |
| Other Current Assets |
11,265,082.07 |
| Total Current Assets |
1,525,440,609.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
378,013,630.02 |
| Investment Properties |
9,519,031.71 |
| Fixed Assetes |
44,241,680.02 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,441,659.40 |
| R&D expenses |
-- |
| Goodwill |
23,755,583.48 |
| Long-Term Deferred and Prepaid Expenses |
1,612,722.54 |
| Deferred Income Tax Assets |
26,833,935.15 |
| Other Non-Current Assets |
15,616,405.31 |
| Sub-Total of Non-Current Assets |
964,229,974.52 |
| Total Assets |
2,489,670,583.87 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
280,000.00 |
| Accounts Payable |
243,682,245.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,849,114.57 |
| Taxes Payable |
6,481,421.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,702,964.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,563,207.69 |
| Other Current Liabilities |
525,562.15 |
| Sub-Total of Current Liabilities |
499,972,622.12 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
528,815.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,722,670.21 |
| Total Liabilities |
510,695,292.33 |
| Paid-In Capital(Or Share Stock) |
337,576,686.00 |
| Capital Surplus |
1,772,795,539.99 |
| Surplus Reserve |
70,934,388.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-202,381,692.29 |
| Minority Stockholder's Interest |
50,369.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,978,924,922.32 |
| Owner's Equity(Stockholder's Equity) |
1,978,975,291.54 |
| Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,489,670,583.87 |